HLA
AGTC

Hamilton Lane Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Hamilton Lane Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-83,951
Closed -$1.76M – 64
2014
Q4 		$1.76M Buy
+83,951
New +$1.71M 0.67% 26

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Hamilton Lane Advisors's AGTC Position: Q1 2015 in Review

Hamilton Lane Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2015, closing a stake of 83,951 shares — an estimated $1.76M sold.

Hamilton Lane Advisors first reported a position in AGTC in Q4 2014 and held it in 1 quarter. The position peaked at $1.76M in Q4 2014. 59 funds tracked by Wall St. Rank hold AGTC as of Q1 2015.

  • Hamilton Lane Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q1 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 83,951 Applied Genetic Technologies Corporation shares in Q1 2015, an estimated $1.76M.
  • Hamilton Lane Advisors first reported a position in Applied Genetic Technologies Corporation in Q4 2014 and held it in 1 quarter.
  • Hamilton Lane Advisors's Applied Genetic Technologies Corporation position peaked at $1.76M in Q4 2014.
  • 59 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2015.

Based on Hamilton Lane Advisors's 13F filing for Q1 2015, filed 8 Apr 2015.